TCS' Market Value Dips by More Than $50 Billion as H-1B Adds to Challenges

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at:

Good morning, this is Ashutosh Joshi, an equities reporter in Mumbai. Indian equity traders can’t catch a break — they’re bracing for yet another round of tariff pain from US President Donald Trump, this time targeting branded drugs. That puts the spotlight squarely on major US-focused players such as Sun Pharma and Biocon, as the pharmaceutical sector suffers alongside software exporters already hit by US visa policies. A down day for the Nifty would mark the first weekly dip in a month. Investors will also be watching the market debuts of Saatvik Green Energy and GK Energy.